Clara Genomics Analysis
Vendor:
First CVE: Aug 29, 2019 · Active for 6 years
1
Total CVEs
Bottom 1%
1.0
Avg CVEs / Year
Bottom 1%
9.8
Avg CVSS
Higher Avg CVSS than 87% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Clara Genomics Analysis over time
Volume of CVEsAvg CVSS Base Score
First CVE
Aug 29, 2019
6 years ago
Most Recent CVE
Aug 29, 2019
2,524 days ago
CVE Severity & Scoring
Clara Genomics Analysis1 CVEs
100%
All CVEs352,785 CVEs
45%
40%
11%
Critical
Attack Vector
Local0 (0.0%)
Network1 (100.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low1 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None1 (100.0%)
Unknown0 (0.0%)
Required0 (0.0%)
Privileges Required
Low0 (0.0%)
High0 (0.0%)
None1 (100.0%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2019-15788CRITICAL Clara Genomics Analysis before 0.2.0 has an integer overflow for cudapoa memory management in allocate_block.cpp. | Aug 29, 2019 | 9.8 | 29 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (1 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (1 CVEs).
Media Mentions
Signals from CVEs in this product scope (1 CVEs).
Top CNAs Publishing CVEs For Clara Genomics Analysis
Top CWEs
Versions
No cataloged versions.